Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S

Clinical trial NCT01556945 · COMPLETED

Trial details

NCT number: NCT01556945
Sponsor: U.S. Army Medical Research and Development Command
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malaria, Falciparum

Start date: 2001-04-01
Primary completion: 2002-02-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.